Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2, COVID-19 and Parkinson’s Disease—Many Issues Need to Be Clarified—A Critical Review
Tsepo Goerttler, Eun‐Hae Kwon, Michael Fleischer, et al.
Brain Sciences (2022) Vol. 12, Iss. 4, pp. 456-456
Open Access | Times Cited: 10

Showing 10 citing articles:

Virus-induced brain pathology and the neuroinflammation-inflammation continuum: the neurochemists view
Jeswinder Sian‐Hülsmann, Peter Riederer
Journal of Neural Transmission (2024)
Open Access | Times Cited: 5
New‑onset non‑motor symptoms in patients with Parkinson's disease and post‑COVID‑19 syndrome: A prospective cross‑sectional study
Anastasia Bougea, Vasiliki Georgakopoulou, Myrto Palkopoulou, et al.
Medicine International (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 10
Exploring the Role of ACE2 as a Connecting Link between COVID-19 and Parkinson’s Disease
Efthalia Angelopoulou, Eleni Karlafti, Vasiliki Georgakopoulou, et al.
Life (2023) Vol. 13, Iss. 2, pp. 536-536
Open Access | Times Cited: 6
A 6-month longitudinal study on worsening of Parkinson’s disease during the COVID-19 pandemic
Ali Shalash, Asmaa Helmy, Mohamed Salama, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug Limitations
Abhishek Kumar Verma, Shea A. Lowery, Li-Chin Lin, et al.
(2024)
Open Access | Times Cited: 1
SARS-CoV-2 hampers dopamine production in iPSC-derived dopaminergic neurons
Gioia Cappelletti, Emma Veronica Carsana, Giulia Lunghi, et al.
Experimental and Molecular Pathology (2023) Vol. 134, pp. 104874-104874
Open Access | Times Cited: 3
Neuroinvasion by SARS-CoV-2 Influences the Prognosis of Neurological Disorders
Poojith Nuthalapati, Mohan Krishna Ghanta, Batoul Farran, et al.
Royal Society of Chemistry eBooks (2024), pp. 272-308
Closed Access
Novel drug delivery system in the management of Parkinson’s disease
Atul Kabra, Ritika Puri, Pradeep Goyal, et al.
Elsevier eBooks (2024), pp. 185-198
Closed Access
SARS-CoV-2, COVID-19 and Neurodegeneration
Lars Tönges, Stephan Klebe
Brain Sciences (2022) Vol. 12, Iss. 7, pp. 897-897
Open Access | Times Cited: 2
Neurological complications in infection with the SARS-COV-2 virus: Parkinson’s disease and the impact on professional reintegration - case study
Maria Valentina Popa, Nicoleta Luchian, Bogdan Gurzu, et al.
Romanian Journal of Occupational Medicine (2022) Vol. 73, Iss. 1, pp. 35-39
Open Access | Times Cited: 1
Page 1

Scroll to top